ArticleAntibodies (Basel, Switzerland)2022

Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients.

Mepur H Ravindranath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.